Panacea Biotec Consolidated March 2022 Net Sales at Rs 140.73 crore, down 16.37% Y-o-Y
1 month ago•Moneycontrol
Panacea Biotec reports consolidated net profit of Rs 1237.42 crore in the March 2022 quarter
1 month ago•Business Standard
Panacea Biotec reports standalone net loss of Rs 25.31 crore in the March 2022 quarter
1 month ago•Business Standard
Panacea Biotec Pharma redeems entire outstanding NCDs
3 months ago•Business Standard
Panacea Biotec shares hit upper circuit in early trade, here’s why
3 months ago•Business Today
Buzzing Stocks | Vedant Fashions, Panacea Biotec, DB Realty, others in news today
3 months ago•Moneycontrol
Mankind Pharma acquires Panacea’s domestic formulation brands for Rs 1,872 cr
4 months ago•Business Today
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data